{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:28:36Z","timestamp":1761060516944,"version":"3.37.3"},"reference-count":32,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2018,2,12]],"date-time":"2018-02-12T00:00:00Z","timestamp":1518393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Asia-Pac J Clncl Oncology"],"published-print":{"date-parts":[[2018,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Aim<\/jats:title><jats:p>To investigate the association of perioperative estimated glomerular filtration rate (eGFR) with prognosis in patients with upper urinary tract urothoelial caicinoma (UTUC).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 433 patients underwent radical nephroureterectomy with excision of the bladder cuff (RNU) at six hospitals affiliated with Kitasato University in Japan. Patients were divided into three groups each in terms of preoperative eGFR: normal eGFR (&gt;60 mL\/min\/1.73 m<jats:sup>2<\/jats:sup>; <jats:italic>n<\/jats:italic> = 172), moderately reduced eGFR (45\u201360 mL\/min\/1.73 m<jats:sup>2<\/jats:sup>; <jats:italic>n<\/jats:italic> = 147) and severely reduced eGFR (&lt;45 mL\/min\/1.73 m<jats:sup>2<\/jats:sup>; <jats:italic>n<\/jats:italic> = 114), and with regard to changes between pre\u2010 and postoperative eGFR: normal change (increased or &lt;10% decreased; <jats:italic>n<\/jats:italic> = 132), moderate change (10%\u201330% decreased; <jats:italic>n<\/jats:italic> = 172) and severe change (&gt;30% decreased; <jats:italic>n<\/jats:italic> = 129). Statistical analyses were performed to investigate the association between perioperative eGFR and prognosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Patients in the preoperative normal and moderately reduced eGFR group had significantly better progression\u2010free survival (PFS) and cancer\u2010specific survival (CSS) than those in the severely reduced eGFR group (both; <jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00.001). With regard to changes in postoperative eGFR, PFS and CSS were significantly better in patients in the severe and moderate change group than in those in the normal change group (both; <jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00.001). When adjusted for the effects of clinicopathological features, pathologic factors were associated with both PFS and CSS, but perioperative eGFR were not independent prognostic factors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Patients with preoperative normal and moderately reduced eGFR and those with severe and moderate change in postoperative eGFR appeared to have a significantly better prognosis.<\/jats:p><\/jats:sec>","DOI":"10.1111\/ajco.12856","type":"journal-article","created":{"date-parts":[[2018,2,13]],"date-time":"2018-02-13T02:47:56Z","timestamp":1518490076000},"source":"Crossref","is-referenced-by-count":7,"title":["Investigation of estimated glomerular filtration rate and its perioperative change in patients with upper urinary tract urothelial carcinoma: A multi\u2010institutional retrospective study"],"prefix":"10.1111","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0731-2579","authenticated-orcid":false,"given":"Dai","family":"Koguchi","sequence":"first","affiliation":[{"name":"Department of Urology Kitasato University School of Medicine  Kanagawa Japan"},{"name":"Department of Urology Kitasato University Medical Center  Saitama Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumasa","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Urology Kitasato University School of Medicine  Kanagawa Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaomi","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Urology Kitasato University Kitasato Institute Hospital  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Taoka","sequence":"additional","affiliation":[{"name":"Department of Urology Kitasato University Medical Center  Saitama Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Hirayama","sequence":"additional","affiliation":[{"name":"Department of Urology Kitasato University School of Medicine  Kanagawa Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6071-218X","authenticated-orcid":false,"given":"Yasukiyo","family":"Murakami","sequence":"additional","affiliation":[{"name":"Department of Urology Kanagawa Prefectural Federation of Agricultural Cooperatives for Health and Welfare Sagamihara Kyodo Hospital  Kanagawa Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuji","family":"Utsunomiya","sequence":"additional","affiliation":[{"name":"Department of Urology Kanagawa Prefectural Federation of Agricultural Cooperatives for Health and Welfare Sagamihara Kyodo Hospital  Kanagawa Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Matsuda","sequence":"additional","affiliation":[{"name":"Department of Urology Higashiyamato Hospital  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihiko","family":"Okuno","sequence":"additional","affiliation":[{"name":"Department of Urology National Hospital Organization Sagamihara Hospital  Kanagawa Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Irie","sequence":"additional","affiliation":[{"name":"Department of Urology Kitasato University Kitasato Institute Hospital  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatsugu","family":"Iwamura","sequence":"additional","affiliation":[{"name":"Department of Urology Kitasato University School of Medicine  Kanagawa Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,2,12]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21254"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200412000-00001"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24135"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-012-2499-8"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2015.02.006"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2011.10288.x"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)67970-0"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2011.05.049"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.5489\/cuaj.827"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2015.3653"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2013.12.048"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-014-1585-7"},{"key":"e_1_2_5_14_1","first-page":"1435","article-title":"Postoperative nomogram for disease recurrence and cancer\u2010specific death for upper tract urothelial carcinoma: comparison to American Joint Committee on Cancer staging classification","volume":"6","author":"Ehdaie B","year":"2014","journal-title":"Urol J"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2012.11649.x"},{"key":"e_1_2_5_16_1","first-page":"403","article-title":"Japan Association of Chronic Kidney Disease Initiatives (J\u2010CKDI)","volume":"54","author":"Imai E","year":"2011","journal-title":"Japan Med Assoc J"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2013.03.032"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(01)01370-X"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2014.05.009"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2008.01.054"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-2042.2006.01429.x"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-012-0347-1"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25043"},{"key":"e_1_2_5_24_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.298.17.2038"},{"key":"e_1_2_5_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2013.04.001"},{"key":"e_1_2_5_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urols.2015.03.004"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep35214"},{"key":"e_1_2_5_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2009.08636.x"},{"key":"e_1_2_5_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2009.07.002"},{"key":"e_1_2_5_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2009.07.035"},{"key":"e_1_2_5_31_1","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.18632\/oncotarget.12239","article-title":"Perioperative treatments for resected upper tract urothelial carcinoma: a network meta\u2010analysis","volume":"8","author":"Yang X","year":"2017","journal-title":"Oncotarget"},{"key":"e_1_2_5_32_1","unstructured":"National Cancer Institute.EA8141 \u2013 Chemotherapy before surgery in treating patients with high grade upper urinary tract cancer. In ClinicalTrials.gov [internet]. National Library of Medicine (US) 2015. NLM Identifier. NCT02412670. Available athttp:\/\/clinicaltrials.gov\/ct2\/show\/NCT02412670."},{"key":"e_1_2_5_33_1","unstructured":"National Cancer Institute.10\u2010208 \u2013 Gemcitabine and cisplatin as neoadjuvant chemotherapy in patients with high\u2010grade upper tract urothelial carcinoma. In ClinicalTrials.gov [internet]. National Library of Medicine (US) 2012. NLM Identifier. NCT01261728. Available athttp:\/\/clinicaltrials.gov\/ct2\/show\/NCT01261728."}],"container-title":["Asia-Pacific Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajco.12856","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajco.12856","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T23:23:54Z","timestamp":1694993034000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ajco.12856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,12]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["10.1111\/ajco.12856"],"URL":"https:\/\/doi.org\/10.1111\/ajco.12856","archive":["Portico"],"relation":{},"ISSN":["1743-7555","1743-7563"],"issn-type":[{"type":"print","value":"1743-7555"},{"type":"electronic","value":"1743-7563"}],"subject":[],"published":{"date-parts":[[2018,2,12]]}}}